- Overview of the RBQM principles
- How can we apply those principles to Vaccine development?
- Vaccine case study from CTQs factors to Submission
Archives: Agenda
Lunch, networking and prize draw
Registration and refreshments
Chair’s opening remarks
Interactive Speaker-Hosted Roundtable Discussions
Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will be led by a table moderator and will focus on a different challenge within clinical data management. Roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.
After 45 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.
| RT 1 | Balancing data, patient and stakeholder priorities in clinical trial design
Hosted by Brian Jingwa, Senior Manager, Team Lead, Global Data Management, Boston Scientific |
| RT 2 | Where does innovation fit in the highly regulated world of clinical trials?
Hosted by Nina Skorytchenko, CEO, Avenna |
| RT 3 | Keeping up your data management strategy at the pace technology is moving at |
Insights into barriers to care in the rare disease community
- Insights on the differences between represented and underrepresents populations on their barriers to care
- Challenges and nuances of rare disease patients’ journey to receive a diagnosis
- Mental health and well-being: the emotional toll rare diseases take on patients and caregivers
- Exploring overall experiences individuals have had within the healthcare system: strengths and areas for improvement
Lunch, networking and prize draw
Rare Disease studies can’t only recruit in US and EU5
- What is a rare disease where?
- Finding patients and rare disease recruitment
- Are there locations that replace Russia, Ukraine and Israel where sadly we cannot work? A look at Asia Pacific